Leukaemia, Lymphocytic, Chronic

Showing 1 - 11 of 11

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Leukaemia, Lymphocytic, Chronic Trial in Worldwide (OFC Infusion, FC infusion)

Completed
  • Leukaemia, Lymphocytic, Chronic
  • OFC Infusion
  • FC infusion
  • Boca Raton, Florida
  • +134 more
Jun 5, 2020

Leukaemia, Lymphocytic, Chronic Trial in Worldwide (Ofatumumab, Observation)

Terminated
  • Leukaemia, Lymphocytic, Chronic
  • Ofatumumab
  • Observation
  • Gilbert, Arizona
  • +202 more
Jul 16, 2019

Leukaemia, Lymphocytic, Chronic Trial in Worldwide (chlorambucil, tablets, ofatumumab (GSK1841157) infusion)

Terminated
  • Leukaemia, Lymphocytic, Chronic
  • chlorambucil, tablets
  • ofatumumab (GSK1841157) infusion
  • Sedona, Arizona
  • +153 more
Jun 5, 2019

Leukaemia, Lymphocytic, Chronic Trial in Australia, New Zealand, United States (Ofatumumab)

Completed
  • Leukaemia, Lymphocytic, Chronic
  • Ofatumumab
  • La Jolla, California
  • +3 more
Nov 8, 2017

Leukaemia, Lymphocytic, Chronic Trial in Japan, Korea, Republic of (ofatumumab 100 mg, 1000 mg / vial)

Completed
  • Leukaemia, Lymphocytic, Chronic
  • ofatumumab 100 mg, 1000 mg / vial
  • Aichi, Japan
  • +6 more
Apr 28, 2017

Chronic Lymphocytic Leukemia (CLL), Leukaemia, Lymphocytic, Chronic Trial in Worldwide (Ofatumumab, Bendamustine)

Completed
  • Chronic Lymphocytic Leukemia (CLL)
  • Leukaemia, Lymphocytic, Chronic
  • Tuscon, Arizona
  • +32 more
Nov 22, 2016

Leukaemia, Lymphocytic, Chronic Trial in Japan (chlorambucil, tablets, ofatumumab (GSK1841157) infusion)

Completed
  • Leukaemia, Lymphocytic, Chronic
  • chlorambucil, tablets
  • ofatumumab (GSK1841157) infusion
  • Aichi, Japan
  • +5 more
Jul 16, 2015

Phase IV Observational Study in Chronic Lymphocytic Leukemia

Completed
  • Leukaemia, Lymphocytic, Chronic
  • (no location specified)
Jul 3, 2014

Leukaemia, Lymphocytic, Chronic Trial (ofatumumab)

Completed
  • Leukaemia, Lymphocytic, Chronic
  • (no location specified)
May 29, 2014

Leukaemia, Lymphocytic, Chronic Trial in Stockholm, Örebro (Ofatumumab)

Completed
  • Leukaemia, Lymphocytic, Chronic
  • Stockholm, Sweden
  • +1 more
Apr 24, 2014

Leukaemia, Lymphocytic, Chronic Trial in Houston, Plymouth (Ofatumumab 500mg, Ofatumumab 1000mg, Fludarabine)

Completed
  • Leukaemia, Lymphocytic, Chronic
  • Ofatumumab 500mg
  • +3 more
  • Houston, Texas
  • +1 more
Dec 19, 2013